| Tag | Content |
|---|
EnhancerAtlas ID | HS012-13996 |
Organism | Homo sapiens |
Tissue/cell | Caco-2 |
Coordinate | chr16:28934910-28935720 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| STAT3 | MA0144.2 | chr16:28935374-28935385 | TTTCCCAGAAG | - | 6.62 | | Stat4 | MA0518.1 | chr16:28935371-28935385 | CTATTTCCCAGAAG | - | 6.16 | | Tcf12 | MA0521.1 | chr16:28934982-28934993 | CAGCAGCTGTT | - | 6.32 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_10806 | chr16:28934105-28937640 | CD19_Primary | | SE_11724 | chr16:28932064-28938989 | CD20 | | SE_54362 | chr16:28934039-28937660 | Spleen | | SE_62078 | chr16:28933981-28957654 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | ATGTGTCTAC ATTGCACAGG CAGGTGGATC CTGAAATGTG GGAAATACAG CCCCAGAGAA 60
GTCTCCAGCC ACCAGCAGCT GTTAGAAAGG GAAATCGCAT GTTGGGAAGG GAATTTTAGG 120
AAGTTTACTC TGGAAGCCAA TGTCAAGGCC ACACTATAGA GGAAGATCTG TGAGAAGGTT 180
GGGACAAAAG TCCAGGAGAG AGTTGACGAG AGCCCCACCG CAGCAGGGGC ATAGCAGCGG 240
GGGCAGCTCT GACATCTGTT TCAGAGTCTC TGGCTTCTGC TAGAGGAAGG AGAGTAGAAA 300
ACAGGATCAG CAGCTGGGGC GTCTGGGGCC AGAGGACCAA GTACAAAGAA CGTGGGGCGG 360
AGGTGGGGAA GCTGGTGCAT GGCGTGGGGT GGAGGGGGGA GTGTCTGGGG AAGGCTAGAG 420
AGCAGAGCAT TAGACTCACA GAGACTGGGC CAGGGCTGAT TCTATTTCCC AGAAGTCCAG 480
ACTAAAATGA GGTTGGTTTG GGGAACTGAG AAGTTTCTCG CCCATCTTCA GGGTTGATCA 540
ATCATCAGTG AGGGACAAGA AATGACATGG GACAAGGCAA CAGATAGAAG CTGGGAGCTA 600
AACTTAGCTA TAACTGACAG AGCTGCTGCT ATCACATGGA GGGCCTCTAT GCAAATTTTA 660
AAAGGGCGGC CCTTCCTCTG GGCCATAGGC ATGCCCTGTG CCAGGCAGCC CTGCTAACCT 720
ATCCCATAGC TTATCTGTGC CCCCAATCCC TTTCTCGTCA TGCACTCCCC AGTATGGGGT 780
TGATGGGGAG TCTAGGTGAG TCCCGCGTCT 810
|
